应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03347 泰格医药
未开盘 04-16 16:08:12
43.780
-0.920
-2.06%
最高
45.140
最低
43.580
成交量
168.56万
今开
44.700
昨收
44.700
日振幅
3.49%
总市值
376.95亿
流通市值
53.90亿
总股本
8.61亿
成交额
7,428万
换手率
1.37%
流通股本
1.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
泰雅科技与阿里云达成全面合作 共建临床试验AI新生态
第一财经 · 04-16 19:17
泰雅科技与阿里云达成全面合作 共建临床试验AI新生态
泰格医药:公司是一家专注于为新药研发提供临床试验全过程专业服务的合同研究组织(CRO)
证券之星 · 04-15 11:34
泰格医药:公司是一家专注于为新药研发提供临床试验全过程专业服务的合同研究组织(CRO)
港股概念追踪 | 创新药板块迎政策东风 国办发文健全药品价格形成机制(附概念股)
智通财经 · 04-15 07:16
港股概念追踪 | 创新药板块迎政策东风 国办发文健全药品价格形成机制(附概念股)
4月14日泰格医药涨6.05%,中欧医疗健康混合A基金重仓该股
证券之星 · 04-14 16:16
4月14日泰格医药涨6.05%,中欧医疗健康混合A基金重仓该股
智通AH统计|4月13日
智通财经网 · 04-13
智通AH统计|4月13日
泰格医药3月无新增发行或股份变动
公告速递 · 04-08
泰格医药3月无新增发行或股份变动
泰格医药新注册《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权
证券之星 · 04-03
泰格医药新注册《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权
泰格医药新注册《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权
证券之星 · 04-02
泰格医药新注册《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权
泰格医药:与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定
人民财讯 · 04-01
泰格医药:与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定
泰格医药涨5.98%,东吴证券一个月前给出“买入”评级
证券之星 · 04-01
泰格医药涨5.98%,东吴证券一个月前给出“买入”评级
泰格医药2025年归母净利润大增119%,扣非净利润下滑58%
蓝鲸财经 · 03-31
泰格医药2025年归母净利润大增119%,扣非净利润下滑58%
CXO概念股强势 凯莱英(06821)涨13.85% 机构认为CXO基本面拐点已经出现
金吾财讯 · 03-31
CXO概念股强势 凯莱英(06821)涨13.85% 机构认为CXO基本面拐点已经出现
异动解读 | 泰格医药2025年第四季度净利润同比大增67.54%,股价盘中大涨5.09%
异动解读 · 03-31
异动解读 | 泰格医药2025年第四季度净利润同比大增67.54%,股价盘中大涨5.09%
泰格医药:关于董事会换届选举的公告
证券日报 · 03-30
泰格医药:关于董事会换届选举的公告
泰格医药(300347.SZ)发布2025年度业绩,归母净利润8.88亿元,增长119.15%
智通财经 · 03-30
泰格医药(300347.SZ)发布2025年度业绩,归母净利润8.88亿元,增长119.15%
泰格医药将于2026年07月31日派发末期股息每股0.13元
公告速递 · 03-30
泰格医药将于2026年07月31日派发末期股息每股0.13元
泰格医药(03347)建议委任萧耀熙为独立非执行董事
智通财经 · 03-30
泰格医药(03347)建议委任萧耀熙为独立非执行董事
泰格医药获Schroders PLC增持38.72万股 每股作价约37.53港元
新浪港股 · 03-30
泰格医药获Schroders PLC增持38.72万股 每股作价约37.53港元
沉寂多时的CRO行业,新一轮行情蓄势待发!
格隆汇 · 03-29
沉寂多时的CRO行业,新一轮行情蓄势待发!
3月27日泰格医药涨5.26%,中欧医疗健康混合A基金重仓该股
证券之星 · 03-27
3月27日泰格医药涨5.26%,中欧医疗健康混合A基金重仓该股
加载更多
公司概况
公司名称:
泰格医药
所属市场:
SEHK
上市日期:
--
主营业务:
杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":43.78,"timestamp":1776326892006,"preClose":44.7,"halted":0,"volume":1685599,"delay":0,"changeRate":-0.020581655480984378,"floatShares":123124800,"shares":861000000,"eps":1.1928863566995624,"marketStatus":"未开盘","change":-0.92,"latestTime":"04-16 16:08:12","open":44.7,"high":45.14,"low":43.58,"amount":74278275,"amplitude":0.034899,"askPrice":43.88,"askSize":300,"bidPrice":43.78,"bidSize":4500,"shortable":3,"etf":0,"ttmEps":1.1928863566995624,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":44.7,"dividendRate":0.007412,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.7294688541441026,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":58.62,"timestamp":1776322800000,"preClose":59.05,"halted":0,"volume":8582400,"delay":0,"premium":"-34.89"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"2627229209","title":"泰雅科技与阿里云达成全面合作 共建临床试验AI新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2627229209","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627229209?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:17","pubTimestamp":1776338245,"startTime":"0","endTime":"0","summary":"据泰格医药消息,2026年4月16日,泰格医药及子公司杭州泰雅语言科技有限责任公司(简称“泰雅科技”)高层代表团赴阿里云云谷园区参观交流。此次访问旨在进一步加强双方在前沿技术领域的互动,双方就临床试验人工智能(AI)技术的应用前景进行了深入探讨,并宣布将在该领域展开全面合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604163707617473.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604163707617473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1201861165.SGD","SG9999014674.SGD","HK0000320264.USD","LU0762541174.USD","LU0791590937.USD","LU0117841782.USD","LU2778985437.USD","IE00BZ08YT58.USD","LU0143863784.USD","LU1044876610.USD","LU1807302812.USD","LU0540923850.HKD","BK1588","LU0320764599.SGD","IE00B0169N27.USD","LU0293314216.USD","LU0605514214.HKD","LU1282649141.HKD","LU1282649810.SGD","IE00BMPRXN33.USD","IE0003895053.USD","LU0594300179.USD","LU0140636845.USD","LU1439103000.SGD","LU0886674414.USD","LU0287142896.SGD","LU0588545904.SGD","LU0061477393.USD","LU1051768304.USD","HBBD.SI","89988","LU1328277881.USD","BK1521","BK1249","LU0164865239.USD","LU1808992512.USD","LU0821914370.USD","LU0043850808.USD","LU0396098781.USD","LU1282649067.USD","LU0165289439.USD","IE00B0JY6N72.USD","LU1961090484.USD","LU0359201885.HKD","LU1720051108.HKD","BK1615","LU2097828714.EUR","LU1282651048.USD","LU0348825331.USD","LU0828237510.HKD","SGXZ90724238.SGD","LU1568876251.USD","LU1044874839.SGD","LU1211504680.USD","LU0543330566.HKD","LU0588545730.USD","LU0650527681.SGD","LU0708995153.HKD","LU0173614495.USD","LU0831093199.SGD","LU1655091459.SGD","LU0128522744.USD","LU0048580855.USD","LU0871576103.HKD","LU1328615791.USD","LU0052750758.USD","LU0608807433.USD","LU2449936058.SGD","LU0449515922.USD","LU2097828805.USD","LU0737861699.HKD","LU1316542783.SGD","LU0417516571.SGD","LU0862451837.USD","LU1770036033.HKD","LU1993786604.SGD","SG9999001689.USD","LU0359201612.USD","LU0210527791.USD","LU0348783662.USD","LU0823426308.USD","BK1610","LU0261947096.USD","LU0163747925.USD","LU0868486357.SGD","LU0516422952.EUR","LU0898667661.SGD","HK0000286598.CNH","LU0096374516.USD","LU0315178854.USD","LU0634319403.HKD","LU1770034418.SGD","LU0477156797.USD","LU1880383366.USD","IE00BZ08YR35.GBP","LU0315179316.USD","LU0651947912.USD","LU2045819591.USD","SG9999001051.SGD","LU0463099449.HKD","LU1719994722.HKD","LU1868838027.USD","LU0149721374.USD","LU1188198961.HKD","BK1591","LU0593848301.USD","LU0823413587.USD","LU0164880469.USD","LU0873338254.USD","LU0819123356.HKD","LU1880398554.USD","LU0572939691.SGD","LU2125910500.SGD","SG9999002828.SGD","LU1880398471.USD","LU2293587155.HKD","LU2125910849.SGD","LU1224444064.USD","LU0169518387.USD","LU0235996351.USD","LU0589944569.HKD","LU0143863198.USD","LU0784639295.USD","LU0607220059.USD","LU0499858602.USD","LU1568876335.HKD","LU0370786039.SGD","SGXZ62798434.SGD","LU0210526637.USD","LU0828237940.HKD","IE00B5MMRT66.SGD","09988","LU0862451753.SGD","BK1501","LU0541501648.USD","LU0594300419.USD","LU0762542818.HKD","LU1688375341.USD","LU2476274720.SGD","SG9999006597.SGD","SG9999002463.SGD","BK1618","LU0345775950.USD","SG9999001093.SGD","ALBmain","SG9999006514.SGD","LU0348783233.USD","SG9999001226.SGD","LU0630378692.HKD","LU1048588211.SGD","LU0456827905.SGD","LU0823426480.USD","LU1515016050.SGD","LU2039709279.SGD","LU0577902298.EUR","LU2488822045.USD","LU0819121731.USD","LU0890818403.SGD","IE0032431581.USD","LU0130518102.USD","LU1224709979.USD","LU0543330483.HKD","LU0561508036.HKD","LU0054237671.USD","LU0320764243.SGD","LU0823397285.USD","LU0048388663.USD","HK0000306685.HKD","LU0708995583.HKD","LU0197773673.USD","LU0328353924.USD","LU0648948544.HKD","LU0651946864.USD","LU0348735423.USD","LU1044875133.USD","LU0856984785.SGD","BK1608","LU0244354667.USD","LU0307460666.USD","HK0000306701.USD","LU0132412106.USD","LU0823038988.USD","LU2357305700.SGD","LU1720051017.SGD","LU0455707207.USD","LU0431992006.USD","LU0611395673.USD","LU0865486749.SGD","LU0229945570.USD","LU1956131251.USD","LU2097828474.EUR","LU0577902371.SGD","LU1366334651.USD","LU1813983027.USD","LU0228659784.USD","LU1642822792.SGD","LU0577902611.USD","LU0541502299.USD","LU0642271901.SGD","LU0264606111.USD","LU0326950275.SGD","LU0228367735.SGD","LU0417516738.SGD","LU1960683339.HKD","LU0314109678.HKD","BK1517","LU1720050803.USD","LU1794554557.SGD","LU0608807946.USD","LU0700851271.USD","03347","LU0164872284.USD","LU2087589342.USD","SG9999000327.SGD","LU1048484197.HKD","LU0049853897.USD","LU0675040207.SGD","LU0648000940.SGD","BK1586","LU0348805143.USD","LU0502904849.HKD","LU0516423174.USD","LU0577902454.USD","SGXZ86797644.SGD","SG9999002562.SGD","LU1242518931.SGD","LU0823041008.USD","LU1242518857.USD","LU0261950983.USD","LU2294711473.HKD","IE0034224299.USD","LU0384037296.USD","LU1366334578.USD","LU0329678337.USD","LU1048596156.SGD","LU0531971595.HKD","LU1051769294.HKD","LU0630378429.USD","HK0000107257.USD","LU0130103400.USD","LU0051755006.USD","LU0072462343.USD","LU0211977185.USD","LU0106959298.USD","LU0254981946.USD","LU2476274308.USD","LU0359202008.SGD","BK1575","LU0048597586.USD","LU0259732245.USD","LU2097828631.EUR","HK0000320223.HKD","LU1548497426.USD","LU0029875118.USD","LU1868837565.USD","LU1880383440.USD","LU0039217434.USD","LU0456846285.SGD","LU0516422366.SGD","LU0572944931.SGD","LU0054450605.USD","IE0008368304.USD","LU0640798160.USD","LU0823397103.USD","LU0572940350.SGD","LU1810669033.SGD","LU0149534421.HKD","LU0320764755.SGD","LU0345776255.USD","LU1769817179.HKD","LU0531970944.HKD","LU0127658192.USD","LU2097828557.USD","LU2242644610.SGD","LU0588545490.SGD","LU0084288322.USD","LU1323998911.USD","LU1831875114.USD","LU0348784397.USD","LU0488056044.USD","LU0196878994.USD","LU1769817096.USD","LU2152927971.USD","LU0577902538.SGD","BABA","LU0047713382.USD","LU0823039010.USD","LU2257852520.SGD","LU1282651121.HKD","LU1115378108.SGD","IE00B543WZ88.USD","LU1023057109.AUD","LU0117844026.USD","LU1251922891.USD","LU0469268626.HKD","LU0588546209.SGD","LU0672654166.SGD","LU0029874905.USD","LU0214875030.USD","LU0181495838.USD","LU0011963245.USD","LU0499858438.USD","LU0441854154.USD","LU0348788117.USD","BK1142","LU0329678170.USD","LU0251144936.SGD","LU0823413660.USD","LU3063872942.SGD","LU0231483743.USD","BK1584","LU0737861772.HKD","LU1196710864.SGD","LU0823040885.USD","SG9999004220.SGD","HK0000151867.HKD","SG9999001903.USD","LU0979878070.USD","LU1504937902.USD","IE00BMPRXR70.SGD","LU1303224171.USD","IE00BPRC5H50.USD","LU0516423091.SGD","LU0128522157.USD","IE00BZ08YS42.EUR","LU0417516902.SGD","LU0348827113.USD","300347","LU0106252389.USD","LU0516422440.USD","LU1981816686.USD","SG9999000459.SGD","LU0197773160.USD","LU0106259558.USD","IE00B3M56506.USD","LU2097829019.USD","LU2399975544.HKD","LU0327786744.USD","LU0762540952.USD","LU0449509016.USD","LU1481107354.HKD","LU0831103253.SGD","BK1502","LU0791591158.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472985","title":"泰格医药:公司是一家专注于为新药研发提供临床试验全过程专业服务的合同研究组织(CRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472985?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:34","pubTimestamp":1776224075,"startTime":"0","endTime":"0","summary":"证券之星消息,泰格医药04月15日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0216","03347","BK1576","BK0028","BK0174","BK1583","BK0077","300347","BK1141","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627245420","title":"港股概念追踪 | 创新药板块迎政策东风 国办发文健全药品价格形成机制(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627245420","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627245420?lang=zh_cn&edition=full","pubTime":"2026-04-15 07:16","pubTimestamp":1776208598,"startTime":"0","endTime":"0","summary":"意见从4个方面提出14条举措,包括完善重点环节药品价格政策、推动相关主体发挥药品价格发现作用、引导关键领域药品价格保持合理水平、加强药品价格治理。具体举措包括优化创新药等新上市药品首发价格机制、发挥医保支付标准对药品价格形成的引导作用、健全药品集中带量采购价格形成机制、完善药品挂网价格管理。《意见》发布后,市场普遍认为新政将为医药产业特别是创新药带来发展新契机。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572944931.SGD","LU1242518931.SGD","LU0181495838.USD","LU0516422366.SGD","LU0979878070.USD","BK4585","IE00B0JY6N72.USD","LU0051755006.USD","LU0140636845.USD","LU2045819591.USD","LU2242644610.SGD","SG9999002463.SGD","03347","LU0348735423.USD","LU0320764599.SGD","LU0043850808.USD","LU0348825331.USD","LU0326950275.SGD","LU0417516902.SGD","LU0856984785.SGD","BK1574","LU1046422090.SGD","BK1161","BK1589","BK1583","LU1242518857.USD","LU0052750758.USD","06127","02315","LU0039217434.USD","LU0456827905.SGD","LU0516423091.SGD","159992","LU2039709279.SGD","LU0823426308.USD","BK1141","02359","02269","LU0516422952.EUR","06978","LU0516422440.USD","VXUS","LU0359202008.SGD","LU0588546209.SGD","LU0819121731.USD","LU0327786744.USD","LU0307460666.USD","LU0708995583.HKD","BK1610","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627416379","title":"4月14日泰格医药涨6.05%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627416379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627416379?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:16","pubTimestamp":1776154570,"startTime":"0","endTime":"0","summary":"证券之星消息,4月14日泰格医药涨6.05%,收盘报59.45元,换手率2.52%,成交量14.28万手,成交额8.22亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共97家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为138.43亿元,最新净值1.8526,较上一交易日下跌0.33%,近一年上涨20.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400025383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","BK1141","BK0174","03347","BK1576","LU1820825898.SGD","300347","159760","LU1146622755.USD","BK1583","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627343879","title":"智通AH统计|4月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2627343879","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627343879?lang=zh_cn&edition=full","pubTime":"2026-04-13 16:15","pubTimestamp":1776068106,"startTime":"0","endTime":"0","summary":"AH统计|4月13日","market":"sh","thumbnail":"https://img.zhitongcaijing.com/images/contents/image_15.png","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/images/contents/image_15.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0572944931.SGD","159982","06865","LU0181495838.USD","03969","01033","LU1366334578.USD","06613","03347","01108","02865","399300","03986","00638","01349","02218","03606","IE00BVYPNP33.GBP","01057","LU0072913022.USD","LU1242518857.USD","00042","01330","03143","03750","00347","IE00BF5LJ272.USD","03968","EWH","03678","02899","06198","00300","01989","00553","06031","LU1064131342.USD","LU1719994722.HKD","02359","06869","01276","02208","LU0648948544.HKD","LU0868486357.SGD","00187","02715","00588","02701","02338"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173438377","title":"泰格医药3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1173438377","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173438377?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:43","pubTimestamp":1775637819,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年4月8日公布截至2026年3月31日的股份变动月报表,报告期涵盖2026年3月1日至2026年3月31日。报告期内,A股与H股均未发生新增发行或减少的情况,公司已发行股份数量保持不变。本月无新增购回或注销事项,与此前购回并持作库存的股份数量也无变动。公司于公告中确认,其截至2026年3月31日继续符合香港联交所主板上市规则关于公众持股量的相关要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568929","title":"泰格医药新注册《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624568929?lang=zh_cn&edition=full","pubTime":"2026-04-03 02:17","pubTimestamp":1775153832,"startTime":"0","endTime":"0","summary":"证券之星消息,近日泰格医药新注册了《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权6个,较去年同期增加了50%。结合公司2025年年报财务数据,2025年公司在研发方面投入了2.58亿元,同比增8.08%。通过天眼查大数据分析,杭州泰格医药科技股份有限公司共对外投资了60家企业,参与招投标项目51次;财产线索方面有商标信息79条,专利信息18条,著作权信息179条;此外企业还拥有行政许可45个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300001860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK0028","LU1820825898.SGD","BK0174","BK1141","BK0216","BK1576","BK0077","BK1583","LU1146622755.USD","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624545579","title":"泰格医药新注册《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624545579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624545579?lang=zh_cn&edition=full","pubTime":"2026-04-02 02:04","pubTimestamp":1775066656,"startTime":"0","endTime":"0","summary":"证券之星消息,近日泰格医药新注册了《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权5个,较去年同期增加了25%。结合公司2025年年报财务数据,2025年公司在研发方面投入了2.58亿元,同比增8.08%。通过天眼查大数据分析,杭州泰格医药科技股份有限公司共对外投资了60家企业,参与招投标项目51次;财产线索方面有商标信息79条,专利信息18条,著作权信息179条;此外企业还拥有行政许可45个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200000796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1583","LU1146622755.USD","300347","BK1576","BK0077","BK0028","BK0174","03347","LU1820825898.SGD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595533","title":"泰格医药:与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595533","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595533?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:19","pubTimestamp":1775031540,"startTime":"0","endTime":"0","summary":"【泰格医药:与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定】泰格医药3月30日在业绩说明会上表示,开年业务亮点:与某全球龙头MNC签署战略合作协议,参与其全球早期临床研究策略制定,提供全方位支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013691912750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0174","BK0028","BK1141","BK1576","BK0216","300347","BK0077","LU1146622755.USD","LU1820825898.SGD","03347","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595849","title":"泰格医药涨5.98%,东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595849?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:16","pubTimestamp":1775031411,"startTime":"0","endTime":"0","summary":"今日泰格医药涨5.98%,收盘报57.05元。2026年2月15日,东吴证券研究员朱国广发布了对泰格医药的研报《泰格医药:临床CRO龙头,扬帆启航新征程》,该研报对泰格医药给出“买入”评级。研报中预计2025-2027年营收71.29/80.19/93.27亿元,同比+7.97%/12.48%/16.31%;归母净利润约11.14/13.57/18.17亿元,同比+175%/22%/34%,对应PE为47/39/29X,首次覆盖,给予“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为光大证券的宋硕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","601555","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623589907","title":"泰格医药2025年归母净利润大增119%,扣非净利润下滑58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623589907","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623589907?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:17","pubTimestamp":1774959423,"startTime":"0","endTime":"0","summary":"公司2025年归母净利润达8.88亿元,同比增长119.15%,但扣除非经常性损益后的净利润为3.55亿元,同比下降58.47%。非经常性损益总额为5.33亿元,占归母净利润比重达59.99%,接近六成。该板块毛利率由29.56%下滑至20.09%,降幅达9.47个百分点,直接导致公司整体毛利率由33.27%下降至26.53%,降幅6.74个百分点。该板块虽仍为第二大业务板块,但其收入占比已退居次席,且盈利能力弱化对扣非净利润产生实质性冲击。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774954342729329489","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623379186","title":"CXO概念股强势 凯莱英(06821)涨13.85% 机构认为CXO基本面拐点已经出现","url":"https://stock-news.laohu8.com/highlight/detail?id=2623379186","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623379186?lang=zh_cn&edition=full","pubTime":"2026-03-31 10:23","pubTimestamp":1774923794,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO概念股强势,凯莱英(06821)涨13.85%,昭衍新药(06127)涨7.34%,药明生物(02269)涨5.99%,康龙化成(03759)涨4.54%,药明康德(02359)涨4.12%,泰格医药(03347)涨2.89%,金斯瑞生物科技(01548)涨1.09%。浙商医药团队分析指出,在CXO产业持续出清,股价相对低位背景下,看好本土头部CDMO企业和受益国内需求复苏CRO企业底部投资机会。从财务、需求和供给数据分析,该机构认为CXO基本面拐点已经出现,并有望持续复苏。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","LU0823426308.USD","LU3063872942.SGD","03347","LU0823426480.USD","HK0000306685.HKD","LU0516422366.SGD","LU0359201612.USD","LU1880383366.USD","IE00B0JY6N72.USD","LU0588546209.SGD","LU0856984785.SGD","06127","LU0456827905.SGD","LU0979878070.USD","LU0456846285.SGD","BK1576","LU1794554557.SGD","LU1328615791.USD","LU0516423091.SGD","LU0052750758.USD","LU0516423174.USD","LU0307460666.USD","LU0051755006.USD","LU0348735423.USD","LU0417516738.SGD","HK0000306701.USD","BK1521","LU0516422440.USD","LU2045819591.USD","CXO","03759","LU0320764599.SGD","LU0326950275.SGD","LU0572944931.SGD","LU0043850808.USD","02359","LU1688375341.USD","BK1589","LU0181495838.USD","LU1242518857.USD","01548","LU0327786744.USD","LU1046422090.SGD","002821","LU0819121731.USD","LU0039217434.USD","LU0140636845.USD","02269","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129225763","title":"异动解读 | 泰格医药2025年第四季度净利润同比大增67.54%,股价盘中大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129225763","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129225763?lang=zh_cn&edition=full","pubTime":"2026-03-31 09:55","pubTimestamp":1774922124,"startTime":"0","endTime":"0","summary":"泰格医药今日盘中大涨5.09%,引起了市场的广泛关注。消息面上,公司发布了2025年年报,其中第四季度单季归母净利润同比增长67.54%,显示出强劲的盈利改善势头,这可能是推动股价上涨的主要原因。根据财报数据,泰格医药2025年第四季度主营收入为18.07亿元,同比上升17.68%;单季度扣非净利润为2913.62万元,同比大幅上升178.32%。尽管全年扣非净利润有所下降,但第四季度的显著增长提振了投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623346850","title":"泰格医药:关于董事会换届选举的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2623346850","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623346850?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:31","pubTimestamp":1774877460,"startTime":"0","endTime":"0","summary":"证券日报网讯3月30日,泰格医药发布公告称,2026年3月30日,公司召开第五届董事会第二十三次会议,审议通过《关于公司董事会换届选举暨第六届董事会董事候选人提名的议案》,提名叶小平先生、曹晓春女士、吴灏先生、闻增玉先生为公司第六届董事会执行董事候选人;提名袁华刚先生、刘毓文女士、萧耀熙先生为公司第六届董事会独立非执行董事候选人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603303689149064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK0216","300347","BK0028","LU1146622755.USD","LU1820825898.SGD","BK0077","BK0174","03347","BK1576","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311294","title":"泰格医药(300347.SZ)发布2025年度业绩,归母净利润8.88亿元,增长119.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311294","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623311294?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:06","pubTimestamp":1774868809,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(300347.SZ)发布2025年年度报告,该公司营业收入为68.33亿元,同比增长3.48%。归属于上市公司股东的净利润为8.88亿元,同比增长119.15%。归属于上市公司股东的扣除非经常性损益的净利润为3.55亿元,同比减少58.47%。基本每股收益为1.04元。此外,拟向全体股东每10股派发现金红利1.26元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101234904","title":"泰格医药将于2026年07月31日派发末期股息每股0.13元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101234904","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101234904?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:11","pubTimestamp":1774861914,"startTime":"0","endTime":"0","summary":"泰格医药(03347)2026年3月30日发布公告,董事会建议派发截至2025年12月31日止年度的末期股息,每10股派发人民币1.26元,相当于每股约人民币0.13元(四舍五入至两位小数),本次股息尚待股东批准。\n根据公告,股东批准日期、除净日、股份过户登记的最后时限、暂停办理过户日期及记录日期均有待公布。公司预期将于2026年7月31日派发股息,实际派息金额及预设派发货币、汇率以及股息涉及的代扣所得税均有待公布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318929","title":"泰格医药(03347)建议委任萧耀熙为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318929","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623318929?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:09","pubTimestamp":1774861796,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(03347)发布公告,根据提名委员会的推荐意见,董事会建议:(1)重选叶小平博士、曹晓春女士及闻增玉先生为第六届董事会的执行董事;(2)重选袁华刚先生及刘毓文女士为第六届董事会的独立非执行董事;及(3)委任萧耀熙先生为第六届董事会的独立非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1146622755.USD","BK0216","BK1141","LU1820825898.SGD","300347","BK0028","03347","BK0077","BK0174","BK1583","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623366195","title":"泰格医药获Schroders PLC增持38.72万股 每股作价约37.53港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623366195","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623366195?lang=zh_cn&edition=full","pubTime":"2026-03-30 07:37","pubTimestamp":1774827420,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示,3月24日,Schroders PLC增持泰格医药(03347)38.72万股,每股作价37.5304港元,总金额约为1453.18万港元。增持后最新持股数目为631.53万股,最新持股比例为5.13%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-30/doc-inhsthzk6657633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300347","BK1576","BK0174","BK0077","BK1583","LU1146622755.USD","BK1141","LU1820825898.SGD","03347","BK0028","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623355908","title":"沉寂多时的CRO行业,新一轮行情蓄势待发!","url":"https://stock-news.laohu8.com/highlight/detail?id=2623355908","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623355908?lang=zh_cn&edition=full","pubTime":"2026-03-29 18:43","pubTimestamp":1774780992,"startTime":"0","endTime":"0","summary":"需求端全面复苏","market":"sh","thumbnail":"https://img3.gelonghui.com/51526-504fcbd8-510f-451e-a009-b9bad64afefe.jpg?guru_height=852&guru_width=1280&guru_size=150086","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/51526-504fcbd8-510f-451e-a009-b9bad64afefe.jpg?guru_height=852&guru_width=1280&guru_size=150086"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4220202","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1141","03347","06978","BK1574","BK1161","BK1583","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622849829","title":"3月27日泰格医药涨5.26%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622849829","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622849829?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:17","pubTimestamp":1774599425,"startTime":"0","endTime":"0","summary":"证券之星消息,3月27日泰格医药涨5.26%,收盘报53.45元,换手率2.66%,成交量15.06万手,成交额7.9亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共96家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为138.43亿元,最新净值1.6652,较上一交易日下跌1.25%,近一年上涨5.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","LU1146622755.USD","BK1576","03347","BK0077","BK1583","BK0174","BK0216","LU1820825898.SGD","BK0028","BK1141","159760"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":0.0549},{"period":"1month","weight":0.0534},{"period":"3month","weight":-0.1786},{"period":"6month","weight":0.035},{"period":"1year","weight":0.7653},{"period":"ytd","weight":0.0291}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0203},{"period":"3month","weight":-0.0168},{"period":"6month","weight":0.0454},{"period":"1year","weight":0.2535},{"period":"ytd","weight":0.0298}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03226},{"month":2,"riseRate":0.5,"avgChangeRate":0.003406},{"month":3,"riseRate":0.5,"avgChangeRate":-0.03269},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.036527},{"month":5,"riseRate":0.4,"avgChangeRate":0.024418},{"month":6,"riseRate":0.6,"avgChangeRate":0.024718},{"month":7,"riseRate":0.6,"avgChangeRate":0.079529},{"month":8,"riseRate":0,"avgChangeRate":-0.091864},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032065},{"month":10,"riseRate":0.5,"avgChangeRate":-0.02594},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001375},{"month":12,"riseRate":0.5,"avgChangeRate":0.041249}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}